Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 802K 935K 751K 688K 1.3M 89.28M 1.3M 8.9M 3.48M 45M 3.51M 3.43M 149M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.77M 13.71M 11.02M 10.09M 19.01M 1.31B 19.06M 130M 51.01M 660M 51.48M 50.37M 2.18B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.43% | +4.97% | +105.90% | +332.82% | 4.18B | |
| +2.29% | -8.57% | +239.67% | +34.31% | 3.66B | |
| +2.38% | +8.30% | +58.20% | +80.68% | 3.56B | |
| +3.63% | +12.33% | +297.18% | +495.77% | 2.64B | |
| -2.91% | +4.01% | -26.20% | -20.95% | 2.33B | |
| -1.35% | +3.37% | +33.43% | - | 1.51B | |
| -3.60% | +3.80% | +269.31% | -16.62% | 1.33B | |
| -2.18% | +3.80% | +19.81% | +45.60% | 1.06B | |
| +1.68% | +22.01% | +34.48% | +180.72% | 679M | |
| Average | +0.26% | +9.43% | +114.64% | +141.54% | 2.33B | |
| Weighted average by Cap. | +1.03% | +6.55% | +129.03% | +165.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.96K 22.47K 20.57K 38.76K 2.67M 38.87K 266K 104K 1.35M 105K 103K 4.45M |
| Net income | -3.35M -3.9M -3.14M -2.87M -5.41M -373M -5.43M -37.16M -14.53M -188M -14.66M -14.34M -622M | -314K -366K -294K -269K -507K -34.94M -509K -3.48M -1.36M -17.61M -1.37M -1.34M -58.27M |
| Net Debt | 10.46M 12.18M 9.79M 8.96M 16.88M 1.16B 16.93M 116M 45.31M 586M 45.73M 44.74M 1.94B | 10.97M 12.78M 10.27M 9.4M 17.71M 1.22B 17.76M 122M 47.53M 615M 47.97M 46.93M 2.04B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
